Table 4.
Proportion of Each Cohort Endorsing Any EQ5D-3L Symptoms Over Time.
| EQ5D-3L domain | Baseline |
1-y follow-up |
||||
|---|---|---|---|---|---|---|
| ECC (n = 87) | Control (n = 125) | P value | ECC (n = 87) | Control (n = 125) | P value | |
| Mobility (EQ5D-M) | 50.0% | 41.5% | .23 | 49.4% | 54.8% | .44 |
| Self-Care (EQ5D-S) | 19.8% | 8.5% | .02 | 16.1% | 7.3% | .04 |
| Usual Activity (EQ5D-U) | 46.5% | 24.6% | <.01 | 42.0% | 25.8% | .02 |
| Pain/Discomfort (EQ5D-P) | 67.1% | 50.9% | .02 | 72.8% | 47.6% | <.01 |
| Anxiety/Depression (EQ5D-A) | 40.0% | 29.7% | .13 | 38.8% | 30.7% | .23 |
Note. ECC = exercise counseling clinic.